ViewPlus VP Rogue Braille Embosser with Tactile Graphics and CRISPR Used For Gene Editing To Treat Leber Congenital Amaurosis

VP Rogue (ViewPlus Technologies - Corvallis, OR)

Dr. Mark Pennesi (Casey Eye Institute, Oregon Health and Science University, Portland, OR)

Dan Gardner, CEO of ViewPlus Technologies, in Corvallis, Oregon, discusses the VP Rogue Sheet and Trac, which are braille embossers, capable of producing high resolution tactile graphics.

Then, Dr. Mark Pennesi, professor of ophthalmology, at Casey Eye Institute, at Oregon Health and Science University, in Portland, explains how a gene editing technique called, CRISPR, can be used to treat Leber Congenital Amaurosis.

10/31/2021 (Click Image Below)